Amneal Pharmaceuticals (AMRX) Income towards Parent Company (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Income towards Parent Company of $69.6 million for Q2 2026, down 10.75% on a QoQ basis from $78.0 million in Q1 2026, and up 95.49% year-over-year from $35.6 million in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Income towards Parent Company (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Income towards Parent Company for 10 years, with the latest figure at $69.6 million in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 95.49% year-over-year to $69.6 million in Q2 2026; TTM through Jun 2026 was $215.3 million, a 320.19% increase from a year earlier, with the FY2025 full-year figure at $127.9 million, up 209.45% from the prior year.
- Income towards Parent Company was $69.6 million for Q2 2026 at Amneal Pharmaceuticals, down from $78.0 million in the prior quarter.
- The five-year high for Income towards Parent Company was $78.0 million in Q1 2026, with the low at -$120.8 million in Q2 2022.
- Average Income towards Parent Company over 5 years is -$659444.4, with a median of $10.7 million recorded in 2023.
- The largest YoY upside for Income towards Parent Company was 460.06% in 2023 against a maximum downside of 2176.69% in 2023.
- Over 5 years, Income towards Parent Company stood at -$4.3 million in 2022, then plunged by 2176.69% to -$98.6 million in 2023, then surged by 78.97% to -$20.7 million in 2024, then jumped by 339.0% to $49.6 million in 2025, then surged by 40.43% to $69.6 million in 2026.
- The last three Income towards Parent Company figures came in at $69.6 million (Q2 2026), $78.0 million (Q1 2026), and $49.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 18.13 Mn |
| Jun 30, 2025 | 35.61 Mn |
| Mar 31, 2025 | 24.62 Mn |
| Dec 31, 2024 | -20.74 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 16.79 Mn |
| Mar 31, 2024 | -81.68 Mn |
| Dec 31, 2023 | -98.65 Mn |
| Sep 30, 2023 | 9.68 Mn |
| Jun 30, 2023 | 11.92 Mn |
| Mar 31, 2023 | -6.94 Mn |
| Dec 31, 2022 | -4.33 Mn |
| Sep 30, 2022 | -2.69 Mn |
| Jun 30, 2022 | -120.81 Mn |
| Mar 31, 2022 | -1.72 Mn |
| Dec 31, 2021 | -6.38 Mn |
| Sep 30, 2021 | -4.24 Mn |
API Access
Amneal Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();